LINDSEY GORHAM: Open Payments
NPI 1235963588 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $100 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $196 |
| PFIZER INC. | 1 | $118 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Genmab U.S., Inc. | 2 | $33 |
| ABBVIE INC. | 1 | $23 |
| Eisai Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: KEYTRUDA, ELREXFIO, LYNPARZA, Tivdak, ELAHERE, Lenvima, JEMPERLI.
Industry payments across MO — which companies pay providers there.
